_________
false
אופקו הלת', אינק
2
380
OPKO HEALTH, INC
Corporation no:
2279206
10802
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
30/12/2017
www.isa.gov.il
www.tase.co.il
Reference:
2017-02-119242
Time of broadcast:
15:00
14:55:29
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Bio-Reference Laboratories, Inc., a wholly-owned subsidiary of OPKO Health, Inc. entered into Amendment to the Credit Agreement to permit BRLI to dividend cash to OPKO. Bio-Reference Laboratories, Inc. חברה בת של אופקו תיקנה את הסכם האשראי שלה על מנת לאפשר חלוקת דיבידנד לאופקו
20171230Form8Ksigned.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NYSE
Date of revision of form structure:
11/12/2017
Address:
Golda Meir
7
,
Nes Ziona
7414002
Israel
,
Israel
Tel:
08-9300051
,
Fax:
08-9300091
E-mail address:
yphilip@opko.com
Company site:
Www.Opko.Com
Previous names of reporting entity:
Name of the Signatory:
Philip Yifat
Position of Signatory in the reporting corporation:
General Counsel
Name of Employer Company:
Address:
Golda Meir
7
,
Nes Ziona
7414002
Telephone:
08-9300051
Facsimile:
08-9300091
E-mail:
yphilip@opko.com
1
Israel